Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2018
Does smoking alter the mutation profile of human papillomavirus-driven head and neck cancers?
Haitham Mirghani, Ludovic Lacroix, Caroline Rossoni, et al.
BJU International
|
March 8, 2008
A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis
Morgan Rouprêt, Vincent Hupertan, David R Yates, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 6, 2014
Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung
Thibault Vieira, Martine Antoine, Anne-Marie Ruppert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage
Morgan Rouprêt, Vincent Hupertan, David R Yates, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 11, 2019
Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study
Camille Mehlman, Jacques Cadranel, Gaelle Rousseau-Bussac, et al.
Cancer Medicine
|
February 17, 2015
Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study
Benoist Chibaudel, Roger Lacave, Marine Lefevre, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 17, 2019
Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project
Michèle Beau-Faller, Erwan Pencreach, Charlotte Leduc, et al.
International Journal of Oncology
|
July 30, 2009
Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer
François M Lemoine, Mustapha Cherai, Camille Giverne, et al.
The European Respiratory Journal
|
March 17, 2018
Cost-effectiveness of <i>KRAS</i>, <i>EGFR</i> and <i>ALK</i> testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study
Sandrine Loubière, Alexandre Drezet, Michèle Beau-Faller, et al.
Analytical Chemistry
|
December 10, 2016
International Interlaboratory Digital PCR Study Demonstrating High Reproducibility for the Measurement of a Rare Sequence Variant
Alexandra S Whale, Alison S Devonshire, George Karlin-Neumann, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2018
Does smoking alter the mutation profile of human papillomavirus-driven head and neck cancers?
Haitham Mirghani, Ludovic Lacroix, Caroline Rossoni, et al.
BJU International
|
March 8, 2008
A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis
Morgan Rouprêt, Vincent Hupertan, David R Yates, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 6, 2014
Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung
Thibault Vieira, Martine Antoine, Anne-Marie Ruppert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage
Morgan Rouprêt, Vincent Hupertan, David R Yates, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 11, 2019
Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study
Camille Mehlman, Jacques Cadranel, Gaelle Rousseau-Bussac, et al.
Cancer Medicine
|
February 17, 2015
Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study
Benoist Chibaudel, Roger Lacave, Marine Lefevre, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 17, 2019
Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project
Michèle Beau-Faller, Erwan Pencreach, Charlotte Leduc, et al.
International Journal of Oncology
|
July 30, 2009
Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer
François M Lemoine, Mustapha Cherai, Camille Giverne, et al.
The European Respiratory Journal
|
March 17, 2018
Cost-effectiveness of <i>KRAS</i>, <i>EGFR</i> and <i>ALK</i> testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study
Sandrine Loubière, Alexandre Drezet, Michèle Beau-Faller, et al.
Analytical Chemistry
|
December 10, 2016
International Interlaboratory Digital PCR Study Demonstrating High Reproducibility for the Measurement of a Rare Sequence Variant
Alexandra S Whale, Alison S Devonshire, George Karlin-Neumann, et al.
Page
of 4